A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective studySheri L. Spunt, Douglas S. Hawkins, Lynn Million et al.|The Lancet Oncology|2019Cited by 182
The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology GroupArchana Shenoy, Erin R. Rudzinski, Susan M. Hiniker et al.|European Journal of Cancer|2020Cited by 27
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology GroupLynn Million, R. Lor Randall, Andrea Hayes‐Jordan et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 15